-
47 children's drugs have been approved for marketing!
Time of Update: 2022-09-09
In recent years, the National Health and Health Commission, the State Food and Drug Administration, the Ministry of Industry and Information Technology, the National Medical Insurance Administration and other departments have also jointly promoted the research and development and production of children's medicines .
-
Innovative drugs have become a new growth point for a large number of pharmaceutical companies, giving birth to new market opportunities!
Time of Update: 2022-09-09
(Image source: Pharmaceutical Network) Hansoh Pharma: Innovative drugs account for more than half of revenue On August 26, the semi-annual performance report released by Hansoh Pharmaceuticals showed that the company achieved revenue of about 4.
-
Within a week, many more drugs were evaluated!
Time of Update: 2022-09-09
On August 25, Northeast Pharmaceutical announced that the company recently received the "Notice of Approval of Drug Supplement Application" on amantadine hydrochloride tablets approved and issued by the State Drug Administration, and the drug passed the consistency evaluation of generic drug quality and efficacy.
-
This multinational pharmaceutical company will lay off more than 1,000 employees! A large number of executives are also on the list
Time of Update: 2022-09-09
In addition to Novartis, a large number of multinational pharmaceutical companies have reported layoffs or even delisting during the year.
In addition to Novartis, a large number of multinational pharmaceutical companies have reported layoffs or even delisting during the year.
-
What is the correct way to eat Tongrentang Wuji Baifeng Wan?
Time of Update: 2022-09-09
Let's learn the correct way to eat Tongrentang Wuji Baifeng Pills, and see how to eat Tongren Wuji Baifeng Pills correctly!The efficacy and composition of Tongren Wuji Baifeng PillAs mentioned earlier, Tongren Wuji Baifeng Pill has the effect of nourishing qi and blood, and regulating liver and kidney.
-
The reform of the pharmaceutical market has intensified, and pharmaceutical companies are facing three major challenges!
Time of Update: 2022-09-09
Competition in the innovation market continues to intensify In recent years, round after round of centralized drug procurement has been accelerating the reform of the domestic pharmaceutical industry .
-
With the continuous acceleration of the review of new drugs, 4 more drugs have been included in the proposed priority review varieties
Time of Update: 2022-09-09
Sanofi China's α of ive glucosidase for injection was approved by CDE on August 15 as a priority review variety for long-term enzyme replacement therapy in patients with Pompe disease (acidic α glucosidase [GAA] deficiency).
-
The Shijiazhuang Municipal Medical Security Bureau actively carried out the pilot work of "pre-hospitalization" management
Time of Update: 2022-09-09
In order to effectively use medical resources, reduce the burden of medical treatment on patients, and improve the operation performance of the medical insurance fund, the Shijiazhuang Municipal Medi
-
The pharmaceutical industry has become a popular track for the fixed increase of public funds
Time of Update: 2022-09-09
According to Wind statistics, the total cost of public fund participation in fixed increase in the same period last year exceeded 60 billion yuan .
According to Wind statistics, the total cost of public fund participation in fixed increase in the same period last year exceeded 60 billion yuan .
-
Bright sword!
Time of Update: 2022-09-08
In May of this year, the Huaihua Municipal Commission for Discipline Inspection and Supervision reported that from November 2011 to April 2021, Wang Yuexin served as the secretary of the Party Committee of the Municipal Hospital of Traditional Chinese Medicine, seeking benefits for related companies in terms of drug supply and medical equipment procurement, and accepted property many times.
-
Many places are vigorously promoting the establishment of "collection of drugs counters" in retail pharmacies!
Time of Update: 2022-09-08
In addition to Changsha, Hunan, Jiangsu has also proposed the construction of "medical insurance convenience pharmacies", that is, through the selection of designated retail pharmacies in townships (streets), the establishment of collection of drugs and state negotiation of drugs counters, the implementation of "zero price difference" sales, so that the grass-roots people can use good drugs of good quality and good price.
-
In the past 30 days, the deputy general managers of 6 pharmaceutical companies such as Silitai and Harbin Pharmaceutical have changed!
Time of Update: 2022-09-08
For example, on August 11, Yihua Health announced that the company's board of directors recently received a written resignation report submitted by Mr. Yan Xiaojia, deputy general manager and secretary of the board of directors.
-
Under the empowerment of digital, pharmaceutical companies are blowing the wind of transformation
Time of Update: 2022-09-08
For example, in the 2022 semi-annual report, Yunnan Baiyao introduced six major performance drivers, including "digital +: keep up with the innovation trend of the pharmaceutical industry and use digital intelligence technology to promote the development of the company".
-
State Food and Drug Administration: Carry out special rectification actions to standardize the production and operation of decorative color contact lenses
Time of Update: 2022-09-08
On August 30, the website of the State Food and Drug Administration announced that the General Department of the State Food and Drug Administration issued a notice on the special rectification action
-
More than 10 listed pharmaceutical companies rushed to disclose the "last train" in the first half of the year! The pharmaceutical company's net profit increased by more than 10,000%
Time of Update: 2022-09-08
34% year-on-year In the first half of the year, Wise Pharmaceutical achieved operating income of 687 million yuan, a year-on-year decrease of 18.
34% year-on-year In the first half of the year, Wise Pharmaceutical achieved operating income of 687 million yuan, a year-on-year decrease of 18.
-
The market for hypoglycemic drugs is huge and the GLP-1RA drug has great potential
Time of Update: 2022-09-08
The 2020 edition of the 2020 version of the Guidelines for the Prevention and Treatment of Type 2 Diabetes issued by the American Diabetes Association (ADA) recommends that patients with atherosclerotic cardiovascular disease (ASCVD) or diabetes with a higher risk of cardiovascular disease should be given priority to use GLP-1RA drugs, and GLP-1RA drugs should be preferred when patients have needs to lower blood sugar and reduce obesity.
-
The competition pattern of the traditional Chinese medicine formula granule industry is good, and the leading enterprises under the market expansion are expected to benefit
Time of Update: 2022-09-08
For another example, Yibai Pharmaceutical disclosed on August 27 the company's progress announcement on the capital increase and share expansion of its subsidiary, Guizhou Yibai Traditional Chinese Medicine Formula Granules Pharmaceutical Co.
-
Pharmaceutical companies are accelerating the promotion of "first imitation", and these companies have gained a lot
Time of Update: 2022-09-08
At present, there are fewer enterprises with fusidic acid cream production approvals, and from the perspective of manufacturer competition pattern, Aomei Pharmaceutical has an exclusive market share of more than 70%.
-
Under the trend of "Internet +", another smart pharmacy officially opened a store for operation
Time of Update: 2022-09-08
In recent years, under the background of the rapid promotion of the Internet + model, which has greatly improved the convenience and satisfaction of the people to seek medical treatment and purchase drugs, many chain pharmacies and pharmaceutical companies are accelerating their exploration.
-
Another batch of pharmacies voluntarily withdraw from medical insurance!
Time of Update: 2022-09-08
For example, some time ago, the Guangdong Huizhou Municipal Medical Insurance Bureau also issued a public notice saying that 109 medical insurance designated retail pharmacies such as Zhengkang Pharmacy in Zhongkai High-tech Zone of Huizhou City intend to terminate the service agreement.
